B. Mlecnik

Zlatko Trajanoski, Patrick Bruneval, Marie Tosolini, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.

S. Bicciato, J. Galon, C. Ries, 2016, Cancer cell.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait Strategy

J. Galon, F. Bibeau, R. Perez, 2020, Clinical Cancer Research.

Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients

M. Speicher, J. Galon, W. Fridman, 2014, Science Translational Medicine.

Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response

J. Galon, S. Nayler, B. Mlecnik, 2022, Cancers.

[Intratumoral immune microenvironment and survival: the immunoscore].

J. Galon, B. Mlecnik, A. Berger, 2014, Medecine sciences : M/S.

Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients.

D. Sargent, P. Ascierto, B. Fox, 2016 .

Intratumoral immune reaction: A novel paradigm for cancer.

J. Galon, W. Fridman, A. Kirilovsky, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SpatiotemporalDynamicsof Intratumoral ImmuneCells Reveal the Immune Landscape in HumanCancer

Z. Trajanoski, M. Speicher, J. Galon, 2017 .

Multiverse of immune microenvironment in metastatic colorectal cancer

J. Galon, B. Mlecnik, G. Bindea, 2020, Oncoimmunology.

Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients

J. Galon, B. Mlecnik, P. Baldin, 2020, Oncoimmunology.

Metastasis immune-based scores predict patient survival

J. Galon, B. Mlecnik, G. Bindea, 2020, Oncoimmunology.

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

F. Marincola, P. Delrio, J. Lee, 2022, Cancers.

Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial.

A. Benson, J. Galon, R. Goldberg, 2022, JCO precision oncology.

Tumor spread or siege immunity: dissemination to distant metastasis or not

J. Galon, B. Mlecnik, G. Bindea, 2021, Oncoimmunology.

Comprehensive functional analysis of large lists of genes and proteins.

Jérôme Galon, Bernhard Mlecnik, Gabriela Bindea, 2018, Journal of proteomics.

CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data

Bernhard Mlecnik, Gabriela Bindea, Jérôme Galon, 2013, Bioinform..

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

Pornpimol Charoentong, Hubert Hackl, Bernhard Mlecnik, 2009, Bioinform..

Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.

J. Galon, W. Fridman, P. Bruneval, 2011, Cancer research.

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

Zlatko Trajanoski, Kurt Zatloukal, Patrick Bruneval, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival

J. Machiels, J. Galon, Y. Humblet, 2018, Journal of the National Cancer Institute.

Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases

H. Heinzl, D. Prayer, G. Ricken, 2016, Oncoimmunology.

Evolution of Metastases in Space and Time under Immune Selection

F. Marincola, M. Ceccarelli, J. Galon, 2018, Cell.

Information technology solutions for integration of biomolecular and clinical data in the identification of new cancer biomarkers and targets for therapy.

Pornpimol Charoentong, Bernhard Mlecnik, Gabriela Bindea, 2010, Pharmacology & therapeutics.

Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin

C. Sautès-Fridman, W. Fridman, I. Cremer, 2013, Clinical Cancer Research.

Erratum: T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells (Cancer Cell (2016) 30(3) (377–390)(S1535610816303890)(10.1016/j.ccell.2016.08.004))

S. Bicciato, J. Galon, C. Ries, 2016 .

The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis

Michael R. Speicher, Marie Tosolini, Amos Kirilovsky, 2016, Science Translational Medicine.

Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy.

J. Galon, T. Frebourg, J. Sabourin, 2015, Cancer research.

Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer

F. Marincola, P. Delrio, J. Lee, 2023, Cancers.

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

F. Marincola, P. Delrio, G. Botti, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Integrating Biomolecular and Clinical Data for Cancer Research: Concepts and Challenges

Pornpimol Charoentong, Hubert Hackl, Bernhard Mlecnik, 2012 .

Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer

J. Galon, P. Bruneval, A. Kirilovsky, 2014, Clinical Cancer Research.

Natural immunity to cancer in humans.

J. Galon, W. Fridman, B. Mlecnik, 2010, Current opinion in immunology.

Complex Portal 2022: new curation frontiers

H. Hermjakob, S. Orchard, L. Perfetto, 2021, Nucleic Acids Res..

PathwayExplorer: web service for visualizing high-throughput expression data on biological pathways

Hubert Hackl, Bernhard Mlecnik, Zlatko Trajanoski, 2005, Nucleic Acids Res..

hSMG-1 is a granzyme B-associated stress-responsive protein kinase

J. Galon, C. Richon, F. Rosselli, 2011, Journal of Molecular Medicine.

The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients.

A. Debucquoy, J. Machiels, K. Haustermans, 2018, Cancer cell.

Correlation between density of CD8 T cell infiltrates in microsatellite unstable colorectal cancers and frameshift mutations: a rationale for personalized immunotherapy Running title: CD8 cell density correlates with mutations in MSI-CRCs

Aurélie, B. Mlecnik, J. Latouche, 2015 .

Coordination of intratumoral immune reaction and human colorectal cancer recurrence.

Pornpimol Charoentong, Z. Trajanoski, J. Galon, 2009, Cancer research.

Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore

N. Lanthier, J. Galon, B. Mlecnik, 2020, The journal of pathology. Clinical research.

L. Zitvogel, G. Kroemer, J. Galon, 2014, Oncoimmunology.

Expand to shield: IL-15 and in situ lymphocytic proliferation

J. Galon, B. Mlecnik, G. Bindea, 2021, Oncoimmunology.

T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.

S. Bicciato, J. Galon, C. Ries, 2016, Cancer cell.

License to kill: microsatellite instability and immune contexture

J. Galon, B. Mlecnik, G. Bindea, 2021, Oncoimmunology.

Abstract 4574: Combining multimodal biomarkers as an immunogram to guide immunotherapy use: A proof of concept

J. Galon, Mihaela Angelova, Laurent Vanhille, 2019, Tumor Biology.

Human Cancer Biology Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases : In fl uence of Tumor Origin

W. Fridman, I. Cremer, M. Riquet, 2013 .

LPL-mediated lipolysis of VLDL induces an upregulation of AU-rich mRNAs and an activation of HuR in endothelial cells.

Z. Trajanoski, R. Zechner, R. Zimmermann, 2006, Atherosclerosis.

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

A. Benson, J. Galon, R. Goldberg, 2020, JNCI Cancer Spectrum.

The immune landscape of human tumors

J. Galon, B. Mlecnik, G. Bindea, 2014, Oncoimmunology.

Automated exploration of gene ontology term and pathway networks with ClueGO-REST

Bernhard Mlecnik, Gabriela Bindea, Jérôme Galon, 2019, Bioinform..

Immune sunrise: from the immunome to the cancer immune landscape

J. Galon, B. Mlecnik, G. Bindea, 2022, Oncoimmunology.

The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival

J. Galon, E. Compérat, P. Camparo, 2021, Cancers.

Immunoscore® as a predictor of response to chemotherapy in stage II and stage III colon cancer

J. Galon, B. Mlecnik, A. Berger, 2015, Journal of Immunotherapy for Cancer.

AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.

J. Zucman‐Rossi, M. Vasseur-Cognet, J. Calderaro, 2018, Journal of hepatology.

Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies

L. Zitvogel, G. Kroemer, J. Galon, 2015, Oncotarget.

molecular mechanisms in tumor-immune cells interaction.

Zlatko Trajanoski, Fátima Sánchez-Cabo, Jérôme Galon, 2011 .

Client-Server environment for high-performance gene expression data analysis

Bernhard Mlecnik, Zlatko Trajanoski, Thomas Truskaller, 2003, Bioinform..

Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy

Pornpimol Charoentong, Z. Trajanoski, J. Galon, 2015, Genome Biology.

Immunoscore clinical utility to identify good prognostic colon cancer stage II patients with high-risk clinico-pathological features for whom adjuvant treatment may be avoided.

F. Marincola, P. Ascierto, I. Nagtegaal, 2019, Journal of Clinical Oncology.

Significant differences in outcome between Immunoscore categories in stage I colon cancer patients.

F. Marincola, P. Ascierto, I. Nagtegaal, 2019, Annals of Oncology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer.

Z. Trajanoski, J. Galon, W. Fridman, 2010, Gastroenterology.

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

K. Zatloukal, Z. Trajanoski, J. Galon, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.

S. Bicciato, J. Galon, C. Ries, 2016, Cancer cell.

Evolution of Metastases in Space and Time under Immune Selection

F. Marincola, M. Ceccarelli, J. Galon, 2018, Cell.

MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies

F. Marincola, P. Ascierto, I. Nagtegaal, 2018, Annals of Oncology.

Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.

Z. Trajanoski, M. Speicher, P. Laurent-Puig, 2016, Immunity.

Database for cancer immunology

M. Thesis, B. Mlecnik, 2003 .

Multi-Institutional Evaluation of Pathologists’ Assessment Compared to Immunoscore

J. Galon, S. Demaria, C. Bifulco, 2023, Cancers.